Three-dimensional polycaprolactone-hydroxyapatite scaffolds combined with bone marrow cells for cartilage tissue...

Current approaches to cartilage repair face limitations in achieving full regeneration and integration with host tissues. Prior research has shown that scaffolds can support cell growth and matrix production, but outcomes remain inconsistent. The chondrogenic potential of scaffolds seeded with autologous cells has not been fully resolved. No prior work had resolved how three-dimensional structures influence osteochondral integration. This gap motivated the exploration of polycaprolactone-hydroxyapatite scaffolds combined with bone marrow cells. The need for better integration of engineered cartilage with surrounding tissues remains unmet. No prior work had resolved the role of scaffold composition in cartilage regeneration. This uncertainty drove the investigation of PCL-HA scaffolds in both in vitro and in vivo settings.

This study aimed to evaluate the chondrogenic potential of PCL-HA scaffolds seeded with bone marrow cells in vitro and their effectiveness in osteochondral repair in vivo. The specific problem addressed is the incomplete regeneration of cartilage and poor integration with host tissues in current repair strategies. The motivation stems from the need for improved scaffolding materials that support both cartilage and bone repair. The goal was to assess whether PCL-HA scaffolds could enhance matrix production and integration. The study sought to compare scaffold-based repair with established techniques like microfracture and autologous transplantation. The focus was on evaluating vertical and lateral integration of the scaffold with host bone. The study aimed to determine if PCL-HA scaffolds could serve as a better alternative for osteochondral repair. The ultimate aim was to identify whether this scaffold design could improve clinical outcomes.

The researchers prepared PCL-HA scaffolds and seeded them with bone marrow cells. The scaffolds were cultured in chondrogenic medium for 10 weeks to assess matrix production. Osteochondral defects were created in the trochlear groove of 29 knees in 17 rabbits. The animals were divided into four groups for treatment comparisons. Group 1 received PCL-HA scaffolds, Group 2 underwent microfracture, Group 3 had autologous osteochondral transplants, and Group 4 served as a control. Histological and morphological analyses were conducted to evaluate cartilage regeneration. The integration of scaffolds with host bone was assessed using imaging techniques. The study used a controlled experimental design to compare scaffold-based repair with standard methods.

After 10 weeks in culture, bone marrow cells produced extracellular matrix that covered the PCL-HA scaffolds. Cartilage lacunae were observed, and matrix accumulation was noted in the scaffolds. In vivo, Group 1 showed excellent vertical and lateral integration with host bone after 12 weeks. However, cartilage regeneration remained incomplete in this group. Group 2 had uneven regenerated cartilage surfaces and reduced matrix distribution. Abnormal bone growth was observed in Group 2, indicating poor integration. Group 3 showed disrupted integration between transplanted and host cartilage. The control group showed no significant repair. These findings suggest that PCL-HA scaffolds support bone integration but fail to fully regenerate cartilage. The results highlight the need for additional factors to enhance cartilage regeneration.

The authors concluded that PCL-HA scaffolds loaded with bone marrow cells improved chondrogenesis in vitro. The scaffolds demonstrated good integration with host bone in vivo but failed to achieve complete cartilage regeneration. The findings suggest that scaffold composition can influence osteochondral repair outcomes. The results indicate that PCL-HA scaffolds may serve as a better alternative than microfracture or transplantation for bone integration. However, cartilage regeneration remained unsatisfactory in this study. The authors propose that the addition of trophic factors could enhance repair outcomes. They suggest that precultured cell-PCL-HA constructs may improve regeneration efficiency. The study highlights the need for further investigation into optimizing scaffold-based cartilage repair.